AzTrials
AzTrials

Post-operative PainNCT02555423

The Effects of Serratus Plane Block Performed Under Direct Vision on Post-operative Pain in Breast Surgery

A study testing Local anaesthetic - chirocaine in people with Post-operative Pain and Serratus Block, run by Kingston Hospital NHS Trust.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to determine the effectiveness of serratus place block in the control of post-operative pain following mastectomy. The investigators will compare one group of patients receiving serratus plane block and wound infiltration to a control group receiving a saline injection into serratus anterior… Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Local anaesthetic - chirocaine
How many people
Not given
Where
No sites listed yet
Study dates
Oct 2015to Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Adult, Older adult

Who may be able to join

  • Patients who undergo mastectomy +/- sentinel node biopsy +/- axillary clearance +/- implant reconstruction will be eligible for the study

Who cannot join

  • Patients under the age of 18.

About this study

The aim of the study is to determine the effectiveness of serratus place block in the control of post-operative pain following mastectomy. The investigators will compare one group of patients receiving serratus plane block and wound infiltration to a control group receiving a saline injection into serratus anterior and wound infiltration with local anaesthetic only. The investigators will compare our results to the National Mastectomy and Breast Reconstruction Audit's reported rate of 6.2% of patients reporting severe pain following mastectomy to see if there is an improvement of the national standard. In the serratus block group, the investigators expect a 50% decrease in the number of patients who report severe pain day one post operatively.

Read the detailed description

Patients who undergo mastectomy +/- sentinel node biopsy +/- axillary clearance +/- implant reconstruction will be eligible for the study. Patients will be consented by Mr Davies preoperatively in the breast clinic at Kingston Hospital to be randomly allocated to one of two groups.

The study will be double blinded and patients will be randomly allocated in to one of two groups as detailed below:

Group 1 - Control Group The first group will act as the control group and will receive wound infiltration with the full amount of local anaesthetic (40mls) around the drain sites and axillary wound, if present, as is standard practice. They will also receive a 20ml injection of 0.9% saline deep to serratus anterior under direct observation. Infiltration of saline will be delivered into 2-3 muscular slips (typically ribs 4-6) in the anterior axillary line. The local anaesthetic will be prepared according to body weight and a dose of 0.375% of chirocaine will be used with the addition of 1:200000 adrenaline and 1 microgram/kg of clonidine.

Group 2 - Serratus Plane Block Group

The second group will receive a serratus plane block and wound infiltration as described below:

The serratus plane block will be conducted by injecting 50% of the total available chirocaine 0.375% with adrenaline and clonidine (20mls) deep to serratus anterior under direct observation. Infiltration will be delivered into 2-3 muscular slips (typically ribs 4-6) in the anterior axillary line. The remaining 50% of local anaesthetic (20mls) will be administered by wound infiltration around the drain sites and axillary wound if present along with a 20ml 0.9% saline injection.

For clarity, please see the table summary below detailing the volumes and locations of local anaesthetic and saline injections in both groups:

20ml local anaesthetic delivered as a serratus block 20ml Saline delivered deep to serratus anterior 20ml local anaesthetic and 20ml saline wound and drain site infiltration 40ml local anaesthetic wound and drain site infiltration Control Group X √ X √ Serratus Group √ X √ X

The purpose of the saline injections is to blind the trial to the surgeon delivering the serratus block.

The anaesthesia for all patients in both groups will be induced using a combination of 0.25mg/kg ketamine, propofol and fentanyl according to standard anaesthetic protocol. All patients will receive 10mg IM morphine intraoperatively. All patients will have regular simple analgesia such as paracetamol and ibuprofen and PRN opiates (tramadol 50-100mg PRN 8 hourly) prescribed for post-operative adjunct pain management.

Patients will be blinded to which group they are randomly allocated to. Written consent and information sheets will be provided to patients and a letter sent to their GP confirming participation in the study.

Data on pain scores and the use of analgesia in recovery, the use of analgesia overnight, the presence of nausea and the pain score and mobilisation status one day after the operation will be collected. The pain score will be assessed using a standard numerical rating scale from 0-10 to score their pain subjectively where:

  • 0 = No Pain
  • 1-3 = Mild Pain (interferes a little with activities of daily living)
  • 4-6 = Moderate Pain (interferes significantly with activities of daily living)
  • 7-10 = Severe Pain (unable to perform activities of daily living)

Patients will also be followed up and one week and 3 months after their surgery to determine their recovery and the presence of any pain. This data will be collected using the FACT - B: Quality of Life Assessment 1 questionnaire.

All collected data will only be stored on NHS trust computer systems.

Being tested
Local anaesthetic - chirocaine
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Local anaesthetic - chirocaineDrug

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To assess the serratus plane block's effectiveness in the management of post operative pain following mastectomy when compared to wound infiltration alone

    Measured: 18 months

Secondary outcomes (1)
  1. To determine the proportion of patients receiving a serratus plane block during mastectomy who go on to develop chronic pain syndromes compared to patients receiving wound infiltration alone

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2015 (estimated)
  2. Study startOct 2015
  3. Primary completionApr 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
IDs, dates and publications
ClinicalTrials.gov ID
NCT02555423
Sponsor's protocol ID
179669
Status last verified
Sep 2015
First submitted
17 Sep 2015
Last updated
21 Sep 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Local anaesthetic - chirocaine in people with Post-operative Pain and Serratus Block, run by Kingston Hospital NHS Trust.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To assess the serratus plane block's effectiveness in the management of post operative pain following mastectomy when compared to wound infiltration alone (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2015; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in